News

European Hematology Association Congress (EHA) 2019 – STRO-001 Poster

June 15, 2019

European Hematology Association Congress (EHA) 2019

Preliminary results of a Phase 1 dose escalation study of the first-in-class anti-CD74 antibody drug conjugate (ADC), STRO-001, in patients with advanced B-cell malignancies.

Please Click the Link,  EHA_2019 STRO-001 poster to enlarge.